<table-wrap xmlns:xlink="http://www.w3.org/1999/xlink" id="tbl1" position="float"><object-id pub-id-type="doi">10.7554/eLife.00429.009</object-id><label>Table 1.</label><caption><p>Intact TORC1 function is necessary for mmBCFA-mediated growth regulation</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.00429.009">http://dx.doi.org/10.7554/eLife.00429.009</ext-link></p></caption><table frame="hsides" rules="groups"><thead><tr><td>Genotype</td><td>RNAi</td><td>Dietary C17ISO</td><td>Normalized % of F1 reached adulthood</td><td>N</td><td>p</td></tr></thead><tbody><tr><td><italic>elo-5(&#8722;)</italic></td><td>Vector</td><td>&#8722;</td><td align="char" char=".">0</td><td align="char" char=".">208</td><td/></tr><tr><td><italic>elo-5(&#8722;)</italic></td><td>Vector</td><td>+</td><td align="char" char=".">86.9</td><td align="char" char=".">205</td><td align="char" char=".">0</td></tr><tr><td><italic>elo-5(&#8722;) nprl-3(&#8722;)</italic></td><td>Vector</td><td>&#8722;</td><td align="char" char=".">71.5</td><td align="char" char=".">69</td><td/></tr><tr><td><italic>elo-5(&#8722;) nprl-3(&#8722;)</italic></td><td>Vector</td><td>+</td><td align="char" char=".">111.5</td><td align="char" char=".">103</td><td align="char" char=".">0.24</td></tr><tr><td><italic>elo-5(&#8722;) nprl-3(&#8722;)</italic></td><td><italic>raga-1 (a)</italic></td><td>&#8722;</td><td align="char" char=".">35.5</td><td align="char" char=".">56</td><td/></tr><tr><td><italic>elo-5(&#8722;) nprl-3(&#8722;)</italic></td><td><italic>raga-1 (a)</italic></td><td>+</td><td align="char" char=".">102.5</td><td align="char" char=".">83</td><td align="char" char=".">0.031</td></tr><tr><td><italic>elo-5(&#8722;) nprl-3(&#8722;)</italic></td><td><italic>raga-1 (b)</italic></td><td>&#8722;</td><td align="char" char=".">25.5</td><td align="char" char=".">214</td><td/></tr><tr><td><italic>elo-5(&#8722;) nprl-3(&#8722;)</italic></td><td><italic>raga-1 (b)</italic></td><td>+</td><td align="char" char=".">88.0</td><td align="char" char=".">279</td><td align="char" char=".">0.00001</td></tr><tr><td><italic>elo-5(&#8722;) nprl-3(&#8722;)</italic></td><td><italic>rheb-1 (a)</italic></td><td>&#8722;</td><td align="char" char=".">14.2</td><td align="char" char=".">351</td><td/></tr><tr><td><italic>elo-5(&#8722;) nprl-3(&#8722;)</italic></td><td><italic>rheb-1 (a)</italic></td><td>+</td><td align="char" char=".">64.6</td><td align="char" char=".">526</td><td align="char" char=".">0.0000001</td></tr><tr><td><italic>elo-5(&#8722;) nprl-3(&#8722;)</italic></td><td><italic>rheb-1 (b)</italic></td><td>&#8722;</td><td align="char" char=".">32.5</td><td align="char" char=".">201</td><td/></tr><tr><td><italic>elo-5(&#8722;) nprl-3(&#8722;)</italic></td><td><italic>rheb-1 (b)</italic></td><td>+</td><td align="char" char=".">86.0</td><td align="char" char=".">116</td><td align="char" char=".">0.0037</td></tr><tr><td><italic>elo-5(&#8722;) nprl-3(&#8722;)</italic></td><td><italic>rsks-1 (a)</italic></td><td>&#8722;</td><td align="char" char=".">15.0</td><td align="char" char=".">68</td><td/></tr><tr><td><italic>elo-5(&#8722;) nprl-3(&#8722;)</italic></td><td><italic>rsks-1 (a)</italic></td><td>+</td><td align="char" char=".">72.5</td><td align="char" char=".">83</td><td align="char" char=".">0.022</td></tr><tr><td><italic>elo-5(&#8722;) nprl-3(&#8722;)</italic></td><td><italic>rsks-1 (b)</italic></td><td>&#8722;</td><td align="char" char=".">19.0</td><td align="char" char=".">183</td><td/></tr><tr><td><italic>elo-5(&#8722;) nprl-3(&#8722;)</italic></td><td><italic>rsks-1 (b)</italic></td><td>+</td><td align="char" char=".">61.0</td><td align="char" char=".">180</td><td align="char" char=".">0.0034</td></tr><tr><td><italic>elo-5(&#8722;) nprl-3(&#8722;)</italic></td><td><italic>ife-2 (a)</italic></td><td>&#8722;</td><td align="char" char=".">10.5</td><td align="char" char=".">144</td><td/></tr><tr><td><italic>elo-5(&#8722;) nprl-3(&#8722;)</italic></td><td><italic>ife-2 (a)</italic></td><td>+</td><td align="char" char=".">71.5</td><td align="char" char=".">49</td><td align="char" char=".">0.003</td></tr><tr><td><italic>elo-5(&#8722;) nprl-3(&#8722;)</italic></td><td><italic>ife-2 (b)</italic></td><td>&#8722;</td><td align="char" char=".">0</td><td align="char" char=".">103</td><td/></tr><tr><td><italic>elo-5(&#8722;) nprl-3(&#8722;)</italic></td><td><italic>ife-2 (b)</italic></td><td>+</td><td align="char" char=".">103.5</td><td align="char" char=".">150</td><td align="char" char=".">0</td></tr><tr><td><italic>elo-5(&#8722;) nprl-3(&#8722;)</italic></td><td><italic>let-363</italic></td><td>&#8722;</td><td align="char" char=".">0</td><td align="char" char=".">&gt;100</td><td/></tr><tr><td><italic>elo-5(&#8722;) nprl-3(&#8722;)</italic></td><td><italic>let-363</italic></td><td>+</td><td align="char" char=".">0</td><td align="char" char=".">&gt;100</td><td align="center">NA</td></tr></tbody></table><table-wrap-foot><fn><p>Percentages of <italic>elo-5(&#8722;);nprl-3(ku540)</italic> homozygotes with the indicated RNAi treatments that reached adulthood, where <italic>(a)</italic> and <italic>(b)</italic> indicate two different RNAi constructs targeting different parts of the same gene. The presented percentage of <italic>elo-5(&#8722;) nprl-3(ku540)</italic> animals that reached adulthood was calculated by normalizing against the percentage of <italic>elo-5(&#8722;/+) nprl-3(ku540)</italic>/+ heterozygotes (see &#8216;Materials and methods&#8217; for detail). Without C17ISO supplementation, RNAi knockdown of multiple TORC1 components reverted <italic>elo-5(&#8722;);nprl-3(ku540)</italic> animals to larval arrest.</p></fn></table-wrap-foot></table-wrap>